LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to ...

Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...

The dorsal cochlear nucleus (DCN) integrates auditory nerve input with a diverse array of sensory and motor signals processed in circuitry similar to that of the cerebellum. Yet how the DCN ...

Investing.com - Canaccord Genuity upgraded Cochlear Ltd. (ASX:COH) from Hold to Buy and set a price target of AUD330.00, citing strong device demand and promising technology developments. The hearing ...

Australian medical device company Cochlear has announced the launch of its Made for iPhone cochlear implant sound processor, providing implant recipients with direct connectivity to their iOS devices.

Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology ...

Older adults fitted with a cochlear implant to compensate for severe hearing loss have significantly poorer cognitive function than their normal-hearing counterparts. Hearing loss is a risk factor for ...